Quick answer
The Wegovy tablet is not licensed specifically for PCOS in the UK. A prescriber may still prescribe it to someone with PCOS who independently meets the weight-management criteria (BMI 30+, or 27-29.9 with a qualifying condition). Any PCOS use is off-label and must be assessed by a registered prescriber, not self-requested.
Wegovy tablets and PCOS UK: what the evidence shows and what to expect
Polycystic ovary syndrome (PCOS) affects an estimated one in ten women of reproductive age in the UK. Weight management is a core component of PCOS treatment — not because PCOS is caused by weight, but because adiposity can amplify insulin resistance, androgen excess and menstrual irregularity. GLP-1 drugs including the Wegovy tablet have attracted interest in the PCOS community as a result.
Important: The Wegovy tablet is not specifically licensed for PCOS in the UK. It is licensed for chronic weight management in adults meeting BMI and co-morbidity criteria. Whether it is appropriate for you as a person with PCOS must be assessed by a prescriber — not self-determined. This page contains information only, not medical advice.
Is the Wegovy tablet approved for PCOS?
No. The MHRA marketing authorisation for the Wegovy tablet (oral semaglutide) covers chronic weight management in adults with a BMI of 30 kg/m² or more, or 27 kg/m² or more with at least one weight-related co-morbidity. PCOS is not one of the listed indications.
However, some prescribers may prescribe the Wegovy tablet to patients with PCOS if the patient also meets the BMI and co-morbidity criteria for weight management. This is a clinical decision made by the prescribing doctor, not something a patient can self-determine or request as an alternative to standard weight management criteria.
What does the evidence show for GLP-1 drugs and PCOS?
While there is no MHRA-approved indication for PCOS, research into GLP-1 drugs and PCOS outcomes has been growing. Key areas of investigation include:
- Insulin resistance: GLP-1 agonists improve insulin sensitivity, which is a core feature of the most common PCOS phenotype.
- Androgen levels: Some studies have observed reductions in androgen excess markers alongside weight loss in women with PCOS on GLP-1 drugs.
- Menstrual regularity: Weight reduction in women with PCOS has been associated with improved menstrual cycle regularity in some studies.
- Fertility outcomes: Research is ongoing. No GLP-1 drug is licensed as a fertility treatment.
These are areas of research interest, not approved indications. The quality and consistency of the evidence varies. A clinical discussion with your GP or endocrinologist is the appropriate starting point — not self-referral to a private online clinic.
Can I get the Wegovy tablet if I have PCOS?
Potentially, if you also meet the standard eligibility criteria (BMI 30+ or BMI 27+ with a relevant co-morbidity). PCOS itself does not make you automatically eligible or ineligible. The prescribing assessment will be based on your overall clinical picture, not on a PCOS diagnosis alone.
See our full eligibility guide for the standard criteria that apply to all patients seeking the Wegovy tablet.
What about metformin — should I stop it?
Metformin is commonly prescribed for PCOS to manage insulin resistance. It is not directly contraindicated with the Wegovy tablet, but any interaction between your existing medications and a new prescription must be assessed by your prescriber. Do not stop or change existing medication without medical guidance.
PCOS and the Wegovy tablet: what to tell your prescriber
If you have PCOS and are considering the Wegovy tablet through a UK provider, be transparent with your prescriber about:
- Your PCOS diagnosis and any co-existing conditions (insulin resistance, thyroid issues, etc.)
- Any medications you currently take (metformin, combined pill, progesterone-only pill, etc.)
- Any fertility treatment you are undergoing or planning
- Whether you are pregnant or breastfeeding (Wegovy is not appropriate in these circumstances)
Find a UK Wegovy tablet provider
If your prescriber determines that the Wegovy tablet is appropriate for you, our live provider tracker compares current prices across all 80+ UK providers we monitor. Prices start from £64/month.
Compare Wegovy tablet prices →
Related pages
Frequently asked questions
Can I take Wegovy tablets if I have PCOS?
Potentially, if you also meet the standard criteria (BMI 30+, or 27-29.9 with a qualifying condition). PCOS alone does not make you eligible or ineligible; a prescriber decides based on your full clinical picture.
Is the Wegovy tablet licensed for PCOS in the UK?
No. Its MHRA authorisation covers chronic weight management at the BMI thresholds only. PCOS is not a listed indication, so any use for PCOS is off-label and at the prescriber's clinical discretion.
Does Wegovy help PCOS weight loss and insulin resistance?
GLP-1 medicines improve insulin sensitivity and support weight loss, and research has explored PCOS benefits. These are areas of investigation, not approved indications. Discuss suitability with your GP or endocrinologist.
Should I stop metformin if I start the Wegovy tablet?
Not without medical guidance. Metformin is not directly contraindicated with the Wegovy tablet, but any medication change must be assessed by your prescriber. Never stop or change medication on your own.
Can Wegovy tablets improve fertility in PCOS?
No GLP-1 medicine is licensed as a fertility treatment. Some research links weight reduction to improved menstrual regularity, but evidence varies. Tell your prescriber about any fertility plans before starting.